Nomad Foods Ltd
NYSE:NOMD
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
15.85
19.93
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Nomad Foods Ltd
You don't have any saved screeners yet
Thank you for standing by. This is the conference operator. Welcome to the Nomad Foods First Quarter 2022 Earnings Conference Call. As a reminder, all participants are in listen-only mode. And the conference is being recorded. [Operator Instructions]
I would now like to turn the conference over to Anthony Bucalo, Head of Investor Relations. Please go ahead.
Hello, and welcome to the Nomad Foods first quarter 2022 Earnings Call. I am Anthony Bucalo, Head of Investor Relations, and I am joined on the call by Stefan Descheemaeker, our CEO; and Samy Zekhout, our CFO.
Before we begin, I would like to draw your attention to the disclaimer on slide two of our presentation. This conference call may include certain forward-looking statements that are based on our view of the company's prospects, expectations and intentions at this time. Actual results may differ due to risks and uncertainties, which are discussed in our press release, our filings with the SEC and this slide in our investor presentation, which includes cautionary language.
We will also discuss non-IFRS financial measures during the call today. These non-IFRS financial measures should not be considered a replacement for and should be read together with our IFRS results. Users can find the IFRS to non-IFRS reconciliations within our earnings release and in the appendices at the end of the slide presentation available on our website.
Please note that certain financial information within this presentation represent adjusted figures for 2021 and 2022. All adjusted figures have been adjusted for exceptional items, acquisition-related, share-based payment and related expenses as well as non-cash FX gains or losses. Unless otherwise noted, all comments from here on will refer to those adjusted numbers.
With that, I will hand you over to Stefan.
Thank you, Tony, and welcome to the team for your first quarterly earnings. Good afternoon, everyone, and thank you all for joining us on the call today. We're pleased to review our results for the first quarter and to report that we are executing well and remain on track to deliver the 2022 guidance we set back in February.
Our business has been significantly disrupted by a difficult macro backdrop, and we see these results as a great achievement for our team. We're not entirely satisfied with our performance, but we are encouraged by the resilience of our business model, the strength of our brands and our ability to navigate difficult waters.
With the war in Ukraine, we faced an unprecedented geopolitical challenge starting the first quarter of 2022. Our input costs have risen sharply year-on-year, while our consumers are coming under increasing pressure from high inflation across Europe. It is with this backdrop that we're focusing on performance and delivery, driving world-class retail execution and strengthening our consumer proposition, while further refining our supply chain through targeting investments and process improvements.
Looking ahead to the rest of the year, we are well hedged on input costs, and we expect at least one more round of price increases to help offset a significant portion of our cost inflation.
Supported by our strong free cash flows, we plan to maintain our investment in brand and supply chain improvements, supporting us in 2022 and beyond. We're also investing in our latest acquisition in Adriatic [ph] we are well positioned for the future.
With that, I'd like to recap our first quarter key financial metrics, beginning with reported revenues of €733 million, which increased by 3.6%, driven by the first year of inclusion of our newly acquired Adriatic business.
Organic revenue declined by 4.5%, reflecting difficult volume comparisons against the COVID lockdown that were still in place this time last year. We delivered an adjusted gross margin of 27.9%, 250 basis points lower year-on-year, reflecting the impact of acquisition, lower organic sales and higher raw material costs.
Adjusted EBITDA of €132 million represents a 4% decline compared to last year, as higher input costs before pricing weighed on the results. And finally, adjusted EPS was €0.43 per share. Although this represents a 9% decline versus last year, we are still on track to deliver our 2022 adjusted EPS guidance of €1.71 to €1.75.
Turning to slide four. In the first quarter, positive revenue growth was driven by the first time inclusion of both Adriatic closer business and a small boost from currency. Our organic sales declined 4.5% as we lapped last year's strong volume results driven by COVIDs lockdowns.
We lost sales in the U.K. due to a poultry shortage and lost sales in another large market due to a pricing dispute with a major retail customer. Stripping out these one-off items, our organic revenues would have been down low single digits for the period. We have since successfully resolved both issues.
We did not get the full benefit of our pricing actions during the quarter, as the pricing was phased [ph] across the period with many of our increases weighted to March. We expect our second quarter sales trends to improve as we get the full benefit of our first quarter pricing and begin lapping post-COVID lockdowns comparison.
However, we do not expect our margin recovery to gain momentum until the second half of the year after we take our next round of pricing on top of our first one from Q1.
Traditionally, we take pricing once annually, acting early in the year. However, we are in a period of unprecedented cost inflation, and we will be taking more pricing midyear to recover costs. We're planning at least one more wave of pricing for the second half of the year, starting early in the U.K. This should boost our top line and help offset the record inflation we are experiencing.
Just to be clear, there is always a time lag between COGS increases, which are linear and our price increases to the retailer, which are staggered. What matters to us is the long-term evolution of our margin, and we believe it is imperative to recover gross profit dollars and margin this year to position us appropriately for next year. We are on track to deliver that recovery in 2023.
Our market share trends were highly encouraging in the quarter. Overall, we grew value share 10 basis points across all of our markets. However, we grew share 60 basis points on average in our top four markets, which represents more than 60% of our sales. These are the must-win battles where we define our commercial success.
Higher input costs weighed on our gross margin and profit in Q1. However, we are well prepared for the rest of 2022 with roughly 85% of our raw material hedged. On energy, we are effectively recovered for 2022 and have begun hedging for 2023.
In edible oils, we have had no shortage to date, and we've taken a covered position on all our requirements for 2022. With this supply crisis, we have accelerated the execution of our risk mitigation strategies, and we have taken step to diversify our sourcing portfolio across key ingredients.
We're also adjusting our product formulations wherever appropriate, while still meeting our high-quality standards. We're also quickly taking steps to reduce the volume of Russian water space we use in our products further derisking our business.
In the year-to-date, we have been highly encouraged by the performance of our new business in the Adriatic region, driven by an outstanding team across the eight markets. Our Easter performance was strong, giving us confidence of a return to pre-COVID tourism levels for the summer selling season when ice cream consumption peaks. The integration program is progressing well, and we are confident we will meet our €15 million synergy target by 2024.
In August 2021, we announced a $500 million buyback program, which expires in August 2024. In Q1, we repurchased nearly €27 million in shares, and we continue to regard share repurchase and highly accretive option to drive shareholder value.
Turning to slide five. This is not the first time Nomad has been tested during a period of uncertainty. Over our history, we’ve passed through multiple challenges and have come out a better company on the other side. After Nomad creation in 2015, we turned the company around and created growth culture in Must Win Battle focus, which is now at the center of who we are today.
We managed through the unique challenge of breaking in 2019 and then the COVID pandemic in 2020 and 2021. We will be challenged this year by high inflation in the war in Ukraine, but I believe we have robust plans in place and are well positioned to deliver to our commitments and come out a strong organization.
In this difficult environment, we are continuing to provide security of supply for our retail partners, and I'm especially pleased with how our supply chain has evolved to meet these new challenges.
In 2020 and early 2021, we navigated the exceptional COVID demand growth when our facilities were running at higher than 90% capacity. Through late 2021 and this year-to-date, we have step-changed our capacity to source, convert and supply at the highest quality despite global shortage of raw materials and exceptional inflationary pressures.
Our current service level improved significantly from a year ago, finishing the first quarter of 2022 at a 96% fill rate, an improvement of 300 basis points versus the same period last year. Additionally, we've maintained our focus on innovation, and we are actively evolving our portfolio to reflect new market realities. This is especially important in light of the rapidly climbing costs for all of our proteins.
Our flagship Green Cuisine plant protein line is gaining share, and we have more innovation planned for the second quarter with that brand. We are also pleased that in the Grocer Gold Award for 2022, Green Cuisine has been short listed for food brand of the Year. In addition, our Proud to Power Team GB for the 2020 [ph] Tokyo Olympics campaign has also been short listed for consumer initiative of the year.
Finally, it is worth noting that even with this difficult backdrop, we are resolute in our focus on our social responsibility commitments. We've maintained our efforts on meeting our OEG goal, especially in the area of net carbon neutrality.
When looking out to the balance of 2022, we believe we are on track to deliver against our most important financial metrics. As Samy will discuss later in more detail, we are guiding to grow our business in line with what we have achieved in recent years.
I believe it is important to look at what we have accomplished in the creation of this business in 2015. After consolidating Birds Eye, Iglo and Findus, we've grown revenues from €1.9 billion to €2.6 billion in 2021 with a run rate this year of €2.9 billion, including a full year of our new Adriatic business. We expect to have more than double adjusted EPS from 2016 to the end of 2022.
We have successfully integrated more than €1 billion of accretive acquisitions, including Goodfellas, Aunt Bessie's and Findus Switzerland, and we plan to add more value-creating strategic assets in the future.
There is volatility in the situation, including our supply chain, and we expect to see some elasticity in our sales this year, but we are confident that our business is well positioned to produce good results under difficult conditions.
Also I'm confident that our growth will accelerate when this period of uncertainty eases, supported by our excellent team across Europe, a strong brand portfolio and a proven track record of deploying capital in an optimal way, driving value for our shareholders.
With that, I will now hand the call over to Samy to review our financial results and guidance in more detail. Samy?
Thank you, Stefan, and thank you all for your participation on the call today. Turning to slide seven. I will provide more detail on our key first quarter operating metrics. We reported revenues of €733 million in the first quarter, a growth of 3.6% year-on-year, driven primarily by the acquisition of our Adriatic business, as a reminder that transaction was finalized in September 2021.
Beyond M&A, first quarter revenues also benefited 1.4 percentage points from favorable FX translation. These growth drivers were offset by a 4.5% decline in organic revenues due to difficult lockdown comparisons, supply chain constraints in the U.K. and the loss of some promotional volume in key markets.
Gross margins were 27.9% during the first quarter, reflecting a 250 basis point decline compared to the prior year and in line with our expectations. This was composed of a 200 basis point decline in our base business, as inflationary pressures impacted margins during the quarter. The remaining 50 basis points contraction was driven by the inclusion of the Adriatic's acquisition, whose gross margin are seasonally lower at this time of the year. Mitigating pricing follow at a lag with further price increase is expected to be implemented through 2022.
Moving to the rest of the P&L. First quarter adjusted operating expenses of €94 million were stable year-over-year. Its year-on-year stability reflects a more normalized level of A&P spend.
We remain committed to supporting our brands with appropriate level of spending. First quarter adjusted EBITDA of €132 million was down 4% versus the prior year, and our adjusted EPS of €0.43 reflected a 9% decline versus the prior year, reflecting the factors previously discussed.
Turning to cash flow on slide eight. We generated €46 million of adjusted free cash flow in the first quarter, equating to 62% free cash flow conversion. This is below Q1 of last year as we are still benefiting from a COVID related tailwind before we rebuilt our inventory position during the remainder of 2021.
Change in working capital switched from a source of cash last year to a €29 million use of cash in this quarter, as we build raw material inventories in anticipation of possible shortages.
While CapEx was flat versus year ago in Q1, we do expect a higher CapEx for the year as we support strategic investment decisions. Changes in both cash interest and cash tax in the quarter were broadly offsetting primarily due to phasing. We expect to deliver strong free cash flows in this year. However, we also expect a combination of stepped-up capital investment, higher inventories and the implementation of the EU's Unfair Trading Practice Directive to leave us short of our typical 90% to 100% medium-term conversion targets.
With that, let's turn to our final slide, slide nine, to review our 2022 guidance, which we are reiterating from CAGNY in our year-end 2021 earnings report in February. Our guidance on sales and EPS is based on our best projections of cost inflation and other factors in the second half of 2022.
As Stefan mentioned in his remarks, we plan to recover cost inflation through several waves of pricing throughout the year, and thus, we expect an improving gross margin profile over the course of 2022. We expect the second wave of pricing to support margin recovery in the second half so that we can start 2023 with an appropriate level of margin.
We remain reactive to market dynamics. Hence, we may need to execute the third wave of pricing towards the end of the year should inflationary pressures persist. The Adriatic's business is weighted towards the second and third quarter, and we expect a favorable mix from the Adriatic's to provide a tailwind to margin during those quarters as well.
So to be clear, we expect a sequentially improving financial performance throughout 2022 based on our improving margin evolution as our pricing takes hold. We expect organic revenue growth in the low single-digit trend for 2022. This will be driven by phased price increases to the first and second half of the year.
Low single-digit growth is consistent with what we guided in February. However, we expect a different mix of volume and price in our sales buildup than in our original guidance.
In our original guidance, we expected a relatively balanced mix of volume and price with a small spread between the two. However, we now expect a wider spread between price and volume with significantly higher pricing, but much more negative volumes as we push for maximum cost recovery.
We expect the Adriatic contribution to revenue to support our reported revenue guidance of high single digits for the full year. All in, we expect adjusted EPS in the range of €1.71 to €1.75 per share, another year of double-digit growth.
That concludes our remarks. I will now turn the session over to Q&A. Thank you. Operator, back to you.
Thank you. We will now begin the question-and-answer session. [Operator Instructions] The first question comes from Robert Moskow with Credit Suisse. Please go ahead.
Hi, thank you. I wanted to ask one question about the guidance. I think you said you might need a third wave of pricing if inflation persists. And I want to know, does that mean that if inflation keeps climbing from here, you'll need a third wave? Or does that mean that if costs stay as high as they are today, you'll need a third wave? And then I'd like a quick follow-up.
Hi, Robert. I mean, actually, what this means is that what we have seen is a steady increase in inflation. And now we're in the middle of, let's say, the execution of the current pricing, which is the second wave. And if effectively inflation keeps on creeping up, if you want, overall, then we would effectively consider third wave at this stage.
Okay. And then my next one, I wanted to make sure I understood your competitive positioning in fish. You've been very transparent about 50% of your supply coming from Russia. And that would seem like a logical thing to present to a retailer to raise price.
But I was wondering if you knew whether your competitors in private label and other brands, are they facing the same challenges as you and therefore, they have to raise as well? Or do you think that you're the one who has to raise more than they do because of your sourcing?
[indiscernible] the question is very simple. Obviously, we don't have the full intelligence, but we have - it's a good intelligence. And our understanding is that our competitors, mostly some brand players, but mostly private label producers are exactly in the same situation if sometimes probably even more dependent on Russian fish. So it's for them. It's re-branding [ph] they're facing the same situation, I would put it that way. I think we're moving quite fast. I can't just for them.
Then in terms of cost increase, I would put it that way, Robert. It's - well, it's broad-based. It's not limited to fish by the way. It's about cost of old [ph] But in terms of fish, well, I don't see why they would have a different situation in terms of price.
The only question they're facing, but I'm not in their shoes is when they are going to decide, obviously, to pass the price, the cost increase, a, from the private label supplier to the retailer and b, from the retailer to the consumers. That is obviously something which is not in my remit. But it's going to come, no matter what. It's more a question of when than if.
Okay, I'll get back in the queue. Thanks.
I would even argue, if you don't mind, that as a private label, you're starting from a lower baseline in terms of price, but you're facing exactly in absolute terms the same kind of COGS increase, which means that in the relative terms, if you - if and when you're going to pass the COGS increase in relative terms, it's going to be a steeper increase.
Got it. Thank you.
The next question comes from Cody Ross with UBS. Please go ahead.
Hey. Good morning, folks. Thank you for taking our question. First question, I'm a little confused about your organic growth guidance for 2022. In your press release, you noted a modest organic revenue decline for the year. And in the slides in your commentary, you noted a low single-digit organic growth. Can you just help us put those two together?
Yeah, sure. I think there has been a corrected statement, I mean, be made in the press release, have just been informed. I mean right now, I think the correct version has been put there. There will be modest growth. The remarks I have put in the speech in the comments on the earnings are the correct ones. It is a modest organic growth for the year. That's what is intended at this stage.
Got it. That's helpful. Thank you for that. And then you held your full year EPS outlook. Many investors we speak with are concerned about the second half operating environment as it gets tougher. Can you just help us understand some of the assumptions underpinning your expectations for the second half, assuming organic sales growth sequentially build, gross margin declines moderate and then operating expense, should we expect that to decline in the back half. Is that the right way to think about it? Thank you.
Yes. I would say, overall, when you take the total map, what we see effectively is a bit of a steady inflation impact across the quarter, more or less, if you have a bit of a ramp-up of gradually, I mean, coming from, let's say, the end of last year getting into this year.
At the same time, we have implemented the first wave of pricing in Q1, which is executed as we speak and where we see the impact, effectively, full-fledge impact as of probably the end of Q1, as we have mentioned. And then we are in the process of implementing the second pricing.
So there is effectively when you look at point-to-point end of December to early January, you see this gradual development of pricing with quite a significant step-up in pricing in other four from an average standpoint to recover the totality of the inflation or at least to end up with an exiting picture, if you want, that would have compensated for the inflation.
So when you take those two elements into consideration, there is an element of neutralization, that's the objective in order to preserve the cost structure and set the right base for 2023. At the same time, effectively, we continue to maintain our cost discipline, we continue to maintain effective to tighten the school [ph] We have made some discretionary intervention that are clearly not impacting the business there.
And we still have some element of protection as we see at this stage in terms of in case effective inflation moves up a bit further. We have talked about the possibility of a third wave, and we do have as well some discretionary intervention that it could trigger should I think if the situation requires some more intervention.
So at this very stage, under the hypothesis effect that we have, I mean, clearly, we feel comfortable with the guidance range that we have a 171 million to 1.75 per share EPS.
Thank you. I'll pass it on.
The next question comes from Steve Powers with Deutsche Bank. Please go ahead.
Yes. Hi, good morning. I was hoping you could give us a little bit more perspective on your raw materials expectations, less from a cost perspective, but more from an availability perspective. I'm most focused on fish, whitefish from Russia, but just more broadly, if relevant.
I guess in the case where EU or U.K. relations with Russia continued to deteriorate and there's a tail risk of excessive tariffs or even importation bands on Russia whitefish. How do you size that risk? And then what are your mitigation strategies in the event that tail risk might actually play out?
Well, we've not been waiting for to materialize. At this stage, to be fair, I think at this stage, we just can be sourced in a normal way. So that's one thing. But at the same time, as we said repeatedly, we're taking step to reduce the volume purchase there. Again, it's not like you switch up and switch on the light. You're talking about fish and you need to breathe to obviously grow the fish on you to make sure that you have the right quality.
It has to be MSC or ASC, so high quality standard, which is really what Nomad is all about. But with that constraint, which is a great constraint, yes, we have - we need to find - we are finding some ways to increase the purchase from outside of Russia. We're working with some replacement in terms of species like haite [ph] for example, which is very close in terms of flesh and taste.
We're starting - and it's something that is going to be significant in the coming years. We're starting with farm fish used. Today, we are something like 98% is wild-caught. But definitely, the future lies also with farm fish provided again that we're dealing with the same kind of quality criteria. So in other words, instead of going to MSC, which is Marine Stewardship Council. We're going to ASC, which is Aquaculture Stewardship Council.
And this is the kind of things we're going to develop together with the farms in - mostly it's in Southeast Asia. So we're taking appropriate steps to get there. And in the meantime, yes, obviously, you're also working with Green Cuisine, which is we have a fantastic product, which is called fishless fingers. And it's working very well, aside, by the way, from any threats. But that's definitely a product that is today one of the best sellers in the U.K., incoming countries like Germany.
And so other options we're taking. But definitely, I can tell you the - let's say, the procurement team and the R&D teams are reasonably busy right now, which is the right thing to do, by the way, because we don't think that there is a way back to the previous situation. So we want to reduce our dependency and we're going to, no matter what happens in the future. So we don't think it's going to be back to a normal situation. And there is a new normal, and we're trying to define this new normal together with those suppliers. That's for fish.
In terms of other materials, well, let's say, aside from the fact that everything has been - the price has been increasing. It's been a broad, let's say, broad-based situation. Big things, I think, coming from these countries is, for example, animal oil. And so it's impacted by the war, but we are contracted for edible oils, and we have taken co-position or no other requirements for 2022. So we have had no shortages to date.
We also use grapeseed oil, as you know, I mean, grapeseed oil has been an important - I mean a lot of people have heard for the first time, sometimes you know, grapeseed oil and how important are this in food. And so we're working with our key suppliers, and we've been working with our peak suppliers to ensure that multi-specs are approved and sought if required. So which is fine. And I think, again, we're doing this without damaging at all the quality standards that we have with Nomad.
Energy is another thing. Obviously, we know what - where we stand at this stage. We have a multiyear cover strategy to - to 2025. We covered in 2022, well hedged in for 2023, starting in 2024. So I think we've taken the right measures. But again, it's not going to stop here. So more to come in the coming weeks, months and quarters.
That is extremely helpful. Thank you for that perspective. If I could ask one follow-up on a different topic. On the second and potentially third rounds of pricing that you're anticipating or contemplating. How - in your low single-digit organic growth guidance, how have you factored in potential retailer friction, as you saw in the first quarter on future waves of pricing? Is that something you've baked into the outlook?
We carry, I mean, of course, I mean, very much, let's say, observing that in the conversation we had. I mean, just to give you some perspective in the context of the first round, and I'll give you some perspective. At the same time, if you want for every price increase we have done historically, we had a number of tension points because this is an exercise that usually start in September, October of the prior year, and that ends up around end of February, depending on the market.
And there has always been a point of, let's say, debate negotiation and so on. This year, we only had one and which had ended up actually in a positive way, which is quite unusual. But that tells you one thing, which is effectively retailers and manufacturers are in the same boat, I mean at this stage. I do think that the simple fact that there is a broad-based inflation, let's say, challenge that's hitting everybody.
There is a matter of frankly preservation of margin even at their end, which they do understand. The question effectively is about talking about funding, if you want the whole pricing and who is going to be effective pricing by the most.
At this very stage, if you want, we have gone pretty successfully in the world, first wave. And in the second wave, we are managing the mix. There are different variable that we have. I just want to highlight to you that pricing is pricing effectively price.
But there's a number of other elements that we are looking at, such as promotion as an example, or potentially, if you want to work in a bit more on the mix working effectively as well on trade terms in order for us to boost the total mix.
That's what we call our revenue growth management strategy. And we are clearly leveraging both sides with purely price and revenue growth management to circumvent some possible risk at this stage. But indeed, I mean, those risks are there, and it's our job to manage the totality of the portfolio of risk in order to deliver against the objective.
Very good. Thank you, both.
The next question comes from John Tanwanteng with CJS Securities. Please go ahead.
Hi, good morning. Thank you for taking my questions and nice quarter. You mentioned that you were 85% hedged on your supply. Where are you open ended at this point, either by feedstock or end market? And kind of what are the risks there that you're looking at?
To your point, I think we hedged 85% until the end of the year, and I think we're making progress moving forward in 2023. The 15% is really, I mean, where there are some categories where it's really difficult on some of our ingredients. It's impossible quasi-impossible to hedge.
So we're pushing the system to the limit. But I'm coming from an environment where we like to hedge 100% on a 12-month basis. I think we're making progress from that standpoint. But when you also need to recognize there are some pieces of the business where it's almost impossible.
Is it - there is nothing that I would like to pinpoint. I think it's more broad-based. But let's say, it's more ingredients, you can - let's say, we mentioned, for example, eggs, that kind of things are more difficult than some other categories, I would put it that way.
You will just - I mean, I'm sure that you're familiar with all of the food business, but an institution like us where you have effectively fish pool free and veg and so on, it's not necessarily in the best interest even of the supplier to really lock in an entire year.
I think the team has done an extraordinary job to get us to the 85% and really pushing even furthermore. But it's really a question of realigning with suppliers and making sure that we can benefit from their production in which other form it is in order for us to look completely for the year the price.
And as Stefan said, there's an antagonism on this one, which is at the same time as we want to get the 85% higher, we need to plan the seeds to frankly get to a proper coverage as for 2023.
Okay. Great. Thank you. And I don't know if you addressed this, but how should we think of your capital allocation priorities, given valuations are down across the board in a number of sectors and assets and including your own shares? Are repurchases more of a priority now? Or is M&A still the focus for you guys?
The message, I mean, is still the same. I mean, clearly, it's all about frankly seeking for the best opportunity to maximize return at this stage. We have - and we've stated effectively that we have an opportunistic approach on that one, and we are in constant assessment of all of the options available, including those that you mentioned. And of course, I mean, porting the business. So that's frankly the view that we have.
Okay, great.
Yeah, sometimes also it's back [ph] by additional commodities by the way…
Okay. If I could ask one more, is your scale enabling you to take share and engage shelf space in a tough environment versus in which competitors are doing at this point?
Sorry, can you say, can you repeat the questions, so I'm not sure that we get it.
Yeah. Is your scale and those supply agreements enabling you to drive shelf space and market share gain in this environment?
Well, I think overall, I think the - all the supply chains have been obviously challenged. No, we're not the only ones. And I would say that in some categories where we have a significant position. Yes, scale is a positive, especially long-term agreements, people remember, especially in more challenging times.
I think I would say - I would call it, frankly, scale and if you know how and category captaincy, retailers are really looking at us clearly to help reshape the share if at some point, there are movements within food across the different sectors. So that clearly - it's not just scale, I think, in itself.
The organization has developed a very deep knowledge, a very deep in-store knowledge and shareholding knowledge whereby the retailers are really looking at us to frankly help them design the shelf, while maximizing from their revenue at their end, and we clearly must say requested or ask to help them in that respect.
Understood. Thank you and good luck.
Thanks.
The next question comes from Ryan Bell with Consumer Edge Research. Please go ahead.
Good morning. Would you be able to discuss how the Fortenova integration is going? And then also maybe give a little bit of an understanding about the recovery on the on-premise broadly across your portfolio, but obviously, specifically for Fortenova in the regions that they operate in?
Well, overall, to make it simple, I mean, the Fortenova acquisition is doing - integration is doing extremely well. By the way, it's an interesting pattern because of all the acquisitions we've been through so far with a clear focus behind frozen food, which I keep believing that the focus is paying off in terms of obviously, Fortenova in terms of how to approach an acquisition, how to generate the synergies.
And every time we're going through another acquisitions, we - I think, or let's say, a model is improving. And Fortenova is really in the middle of this.
So first, the first thing is what we've seen after an extensive due diligence is no real surprise. By definition, you always have surprises. But let's say, at this stage, we have more good surprises and bad surprises. That's one thing.
The team is extremely supportive, extremely excited to be part of being a core strategy of the organization, which is a big change for them. And I can tell you in terms of energy, it's a huge - it makes a huge difference. People also want to learn and I think we have, let's say, some interesting tools that they can take.
And on top of that, to your point, I think we also have - back to on-premise. We think it's a great asset for ice cream, but also for frozen food. We have 120,000, let's say, freezers across the organization. It's part of our CapEx, by the way. It's something that we knew from the start that we need to obviously read, let's say, improve the quality of the assets is something we're doing right now just in the last piece of it right now for this year.
And what we've seen at least so far is Easter has been extremely good for us. So we're starting to come back to a pre-COVID situations in terms of ice cream because this is obviously, let's say, out-of-home, imports was a bit on obviously has been, let's say, there were some issues during COVID. I think we can see it's improving big time.
So we're quite confident that what was going to happen in the summer is going to be extremely helpful with a very good team, improve the infrastructure, new tools and post-COVID. So yeah, I think it's - we really like the acquisition. And by the way, we also love the margins, imports, ice cream, gosh, it's a great margin. We love it.
If I could just ask one more. You took phased pricing throughout 1Q, and you highlighted a significant portion of that actually came towards the back half or the back end of the quarter. Would you be able to talk about the depth of the price increases kind of as we got towards the end of the quarter, just to understand the magnitude of the full effect of those pricing?
Yeah. I think the comment was really just to talk more about the pricing impact on the sales and execution. The reality is that in the FMCG world, when you pass the list price, you have to support your business during transition time and you have to put in place the relevant level of promotions, together with the retailer in order to facilitate the transition from a given price point to another price point. So managing your promotion during the price increase is essential.
So what happens is, just to pick an example, if you have a market that's technically raising prices on Jan 1, you rarely, if you want a net impact on your net sales of pricing, you start to see the effect after probably 45 days or so, 45, 50 days on average.
So it's not that we have deferred the execution. I think what's really important was that we did execute the price, actually, even the U.K. started even earlier than that, but the majority of the markets have executed all of the pricing between Jan and February. But let's say, the ramp-up of the effect on a net basis after promotion is really hitting most as of March, let's say.
And would you be able to say kind of the size of that pricing on a percentage basis?
Yeah. I think it's quite bold. I think it's in the range probably of the mid single-digit level, I mean at this stage, depending on the market. Some of them was a bit on the high end of the, let's say, single-digit, the other one we're really closer to the mid-single, but the average is probably around the mid-single from the least price execution standpoint, not after promotions least price.
Thanks so much.
Welcome.
[Operator Instructions] The next question comes from Robert Moskow with Credit Suisse. Please go ahead.
Hi. Just a follow-up. The frozen category in Europe, the data looks pretty weak. Declines have continued. I thought it was due to increased mobility among consumers. How is the category doing compared to others in Europe? And has that influenced at all the retailer’s willingness to allow higher pricing to go through? Thanks.
Well, I think to start with the second part, I don't think it doesn't - I don't think it impacts the willingness to come up with prices because they also, by the way, as you know, I mean, they are private labels. So they're going through the same kind of COGS as us. So that would be a big mistake and they're not making this mistake.
To your point, I think at this stage, yes, let's say, frozen is a bit weaker than the others. But you need also to remember that during the same period last year - I mean doing COVID, significantly over performed the other categories, ambient and perishable.
So overall, and when you see on a two year basis, we're still doing very well. So I'm not concerned, but definitely, we want to see, obviously, things moving on. So that's one thing.
So yes, that's - we very much you're taking a longer term approach of two years approach, three year approach. The numbers are very, very consistent. I also believe, by the way - and I don't know if you noticed that we've come up with an announcement in terms of sustainability and the LCA, which is life cycle assessment.
We've come up with a study, a very thorough study, by the way, end-to-end in terms of, let's say, or 22 bigger SKUs. And we compared the carbon footprint end-to-end really from, let's say, the field to the fork with the equivalent in, let's say, in fresh or in ambient.
And I think for most of them, we're doing eat [ph] or better than these guys. And the reason is most of the time its attributed to waste because the waste level at the store level is obviously much better for us, same thing for the consumers.
So I think one thing what we need to probably communicate better is also waste is great in terms of sustainability or less waste, but it's even better for the disposable income. So in other words, if you - if you're going to save money on a full year basis, if you go to the same price with frozen foods because the waste level is just much lower, not only at the retailer level, but also the consumer.
So that's the kind of things that we believe that the fundamentals of gross type age. And at this stage, as I said, yes, it's a bit weaker. But when you're taking the long-term expense, as I mentioned…
Okay. Thank you.
The next question comes from Cody Ross with UBS. Please go ahead.
Hey, there. Thank you for taking our follow up. Just a quick question. You only repurchased $27 million of shares, stock is down 30% this year, and you have nearly €400 million left in dry powder. At what point would you consider accelerating your share repurchase? Thank you.
Yeah, I'm going to repeat the message I gave you. I mean before we have made those repurchase effectively prior to the Ukraine war. And we made it very clear, actually, in our communication that the priority for us is to make sure that we clearly had access to supply in order to serve our consumers that was really important. And that's why effectively, we spent probably more money in inventory in building up. I mean, those things that were necessary to have our plan functioning, our full regime, I mean from that perspective.
So from a general standpoint, if you want, as we generate cash, if you want, let's say, quarter-after-quarter, we're looking at effectively the best way to allocate this capital. And frankly, at this stage, frankly, there is no, let's say, sequel [ph] but there we're just after shareholder value maximization. And we are in a constant, let's say, look of that, taking into consideration, of course, the external environment, which is all about effective supply availability, the question was raised earlier.
So I think it's - there's no magic formula. There's not going to be a threshold to say, but it's all about really what's affecting the right mix that's going to get us the maximization of shareholder value.
This concludes the question-and-answer session. I would like to turn the conference back over to Stefan Descheemaeker for any closing remarks.
Thanks, operator, and thank you for your participation on today's call. 2022 has gotten off to a challenging start, but we're optimistic. Yes, the troubling war in Ukraine has presented us with a difficult set of hurdles, as it has for everyone around the globe. But we are encouraged by the great people working at Nomad, a fruitful partnership with our retail customers and our loyal consumers. We remain focused on delivering our business objectives even in these tumultuous conditions.
Frozen food is, as I said, a healthy, nutritious, affordable option for all families, especially during difficult times like these. Our business is built to survive in tough conditions, and we expect to come out of this crisis stronger than before. We delivered a fifth consecutive of record financial performance in 2021, and we expect to do so again in 2022.
This concludes today's conference call. You may disconnect your lines. Thank you for participating, and have a pleasant day.